-
Beginning calendar year 2014, this will increasingly include generic pharmaceutical products that Walgreen has so far self-distributed.
FORBES: Quick Take
-
Bernstein analyst Ronny Gal, given the proportion of pharmaceutical revenues now generated by biologic products traditional generic drug manufacturers have little choice but to pursue biosimilar development.
FORBES: Gamekeeper or Poacher? - Big Pharma's Stance on Biosimilars
-
Anchen is a profitable pharmaceutical company that develops and commercialized extended release and niche generic products.
FORBES: Pharma News: United Therapeutics, Zogenix, Par Pharmaceuticals
-
Akorn is a niche generic pharmaceutical company that develops, manufactures and markets pharmaceutical products in the areas of ophthalmology, antidotes and anti-infectives in addition to controlled substances for pain management and anesthesia.
FORBES: Akorn Stock Has Healthy Upside
-
AmerisourceBergen is a pharmacy services provider and will distribute branded pharmaceutical products that Walgreen has historically distributed, and it will help Walgreen source and distribute generic drugs internationally potentially bringing both growth and better purchasing power with drug manufacturers.
FORBES: Quick Take
-
Clark added the company's Clinical and Medical Products sector will be a key growth driver, and expects to benefit from new generic pharmaceutical launches and improvements in operational performance.
FORBES: Magazine Article